Tribun Health enters pharmaceutical market
April 27, 2022—Tribun Health, formerly Tribvn Healthcare, announced its expansion into the pharmaceutical market with the appointment of Loic Dartois as vice president of pharma.
Webinars and Sponsored Roundtables — Register Now
Tuesday, June 9, 2026, 1:00–2:00 PM ET
In this webinar, we will examine how immune recognition after allogeneic HCT can influence leukemia relapse and disease progression. The session will highlight the clinical relevance of HLA loss of heterozygosity (LOH), approaches used for its detection, and how LOH findings may support transplant strategies, including considerations for donor selection in subsequent transplantation.
Webinar presenter Alberto Cardoso Martins Lima, PhD, Clinical consulting scientist in histocompatibility,
specializing in allogeneic hematopoietic cell transplantation (HCT) at IGEN/AFIP São Paulo and CHC/UFPR in Curitiba, Brazil
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice
Webinar presenter Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, July 15, 2026, 1:00-2:00 PM ET
Hear an expert discuss how to integrate Kappa and Lambda in situ hybridization testing into your standard hematopathology workflow to accurately assess B-cell and plasma cell clonality. You will also gain the skills to recognize testing pitfalls in challenging reactive versus neoplastic proliferations and apply ancillary tools to resolve complex cases.
Webinar presenter Xiaojun Wu, MD, PhD, Assistant professor, Director of Hematopathology Section at NCR of Johns Hopkins Medicine Department of Pathology, SOM at Johns Hopkins University
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Subspecialties
Interactive Product Guides
Industry News
Accelerate Diagnostics presents performance data at ECCMID
April 22, 2022—Accelerate Diagnostics announced the release of new performance data on the Accelerate Arc module and blood culture kit.
Versant Dx launches strategy to accelerate digital pathology
April 21, 2022—Versant Diagnostics has announced a strategy to “drive the digital revolution in pathology,” with a focus on anatomic pathology, precision medicine, and the digital transformation of the industry.
PreciseDx AI-enabled digital pathology detects Parkinson’s
April 20, 2022—PreciseDx today announced its artificial intelligence–enabled digital pathology technology can accurately diagnose Parkinson’s disease in patients prior to the severe onset of symptoms.
FDA authorizes COVID-19 breathalyzer test
April 15, 2022—The FDA issued an emergency use authorization to InspectIR Systems for its InspectIR COVID-19 Breathalyzer test.
BioMérieux acquires Specific Diagnostics
April 12, 2022—BioMérieux has entered into an agreement to acquire Specific Diagnostics, a privately held U.S.-based company that developed a rapid antimicrobial susceptibility test system.
Tempus unveils Edge pathology-driven AI platform
April 1, 2022—Tempus has announced plans to launch Edge, a platform that will enable pathology practices to access the company’s digital pathology AI models, during the second half of this year.
Accelerate Diagnostics launches Arc module, BC kit
March 28, 2022—Accelerate Diagnostics launched the Accelerate Arc system for rapid and accurate microbial identification of positive blood cultures.
BioMérieux gets FDA 510(k) clearance for Vitek MS Prime
March 18, 2022—BioMérieux announced the Vitek MS Prime, its new MALDI-TOF mass spectrometry identification system, received FDA 510(k) clearance.
CE-marked Nova Max Pro creatinine/eGFR meter launched
March 11, 2022—Nova Biomedical launched the CE-marked Nova Max Pro creatinine/eGFR meter system in the EU market.